^†TOBI Podhaler was evaluated for safety in 425 patients with CF exposed to at least 1 dose of TOBI Podhaler, including 273 patients who were exposed across 3 cycles. The most common side effects of TOBI Podhaler include cough, worsening of lung problems or cystic fibrosis, productive cough, shortness of breath, fever, sore throat, changes in voice (hoarseness), coughing up blood, headache, and altered taste.

^‡This Savings Card can be used to reduce the amount of your out-of-pocket expenses for TOBI^® Podhaler^® up to a maximum of $14,000 per calendar year while this program remains in effect, with no monthly limit. Mylan Specialty L.P. reserves the right to amend or end this program at any time without notice. This Savings Card can be redeemed only by patients or patient guardians who are 18 years of age or older and who are residents of the United States and its territories. Patients must have commercial insurance. This program is not valid for uninsured patients (but may be used by commercially insured patients without coverage for TOBI^® Podhaler^®) and patients who are covered by any state or federally funded healthcare program, including but not limited to any state pharmaceutical assistance program, Medicare (Part D or otherwise), Medicaid, Medigap, VA or DOD, or TriCare (regardless of whether TOBI^® Podhaler^® is covered by such government program); not valid if the patient is Medicare eligible and enrolled in an employer-sponsored health plan or prescription benefit program for retirees; and not valid if the patient’s insurance plan is paying the entire cost of this prescription. This program is void outside the US and its territories or where prohibited by law, taxed, or restricted. Absent a change in Massachusetts law, this program will no longer be valid for Massachusetts residents as of January 1, 2021. For full terms and conditions, visit www.activatethecard.com/tobi.